Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

First Direct Measurement Of Spinal Cord Myelin In MS

First Direct Measurement Of Spinal Cord Myelin In MS

24 Sep 2013
Researchers develop first imaging tool to examine myelin damage in MS

Researchers develop first imaging tool to examine myelin damage in MS

24 Sep 2013
Almirall and GKV-SV reach agreement on pricing of Sativex medicine in Germany

Almirall and GKV-SV reach agreement on pricing of Sativex medicine in Germany

23 Sep 2013
Antibody that binds, neutralizes HIV likely also targets the body's own self proteins

Antibody that binds, neutralizes HIV likely also targets the body's own self proteins

20 Sep 2013
Researchers discover new mechanism involving p53 to fight against aggressive cancers

Researchers discover new mechanism involving p53 to fight against aggressive cancers

20 Sep 2013
New evidence suggests that taking vitamin B supplements may help reduce risk of stroke

New evidence suggests that taking vitamin B supplements may help reduce risk of stroke

19 Sep 2013
Wayne State University initiates groundbreaking multiple sclerosis study

Wayne State University initiates groundbreaking multiple sclerosis study

19 Sep 2013
GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

GW Pharmaceuticals starts GWP42006 Phase 1 clinical trial for epilepsy treatment

18 Sep 2013
University of Chicago researchers awarded NIH grant to develop novel multiple sclerosis treatment

University of Chicago researchers awarded NIH grant to develop novel multiple sclerosis treatment

18 Sep 2013
UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

UCSF neuroscientist wins Barancik Prize for multiple sclerosis research

17 Sep 2013
Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

Scottsdale Healthcare, TGen initiate Thunder God vine clinical trial in pancreatic cancer patients

13 Sep 2013
Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

Research: Treatment with antioxidants may help reduce behavioral issues linked to NF1

12 Sep 2013
New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

New HIV/AIDS vaccine candidate appears to clear AIDS-causing virus from body

12 Sep 2013
Study: People who get occasional migraines are more likely to be obese

Study: People who get occasional migraines are more likely to be obese

12 Sep 2013
Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

11 Sep 2013
Rutgers scientist finds important clue on origins of multiple sclerosis

Rutgers scientist finds important clue on origins of multiple sclerosis

11 Sep 2013
Little STING could go long way in avoiding arthritis, type 1 diabetes, report researchers

Little STING could go long way in avoiding arthritis, type 1 diabetes, report researchers

10 Sep 2013
UCSF scientists identify new way to manipulate immune system from autoimmune diseases

UCSF scientists identify new way to manipulate immune system from autoimmune diseases

10 Sep 2013
Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

Avanir Pharmaceuticals, Wockhardt settle patent litigation related to NUEDEXTA capsules

7 Sep 2013
Researchers find safety mechanism in immune system in people with autoimmune diseases

Researchers find safety mechanism in immune system in people with autoimmune diseases

6 Sep 2013

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback